SCHEMBL2003391

SCHEMBL2003391

CCCc1cc(C(=O)O)ccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.53
KDM4E B2RXH2 2/20 0.53
GAA P10253 2/20 0.53
MAPT P10636 2/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
PTGS2 P35354 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
PTPN1 P18031 1/20 0.50
PTPN11 Q06124 1/20 0.50
HTT P42858 4/20 0.49
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
PKM P14618 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL900912 0.89 RARB (0.51) POLBKDM4EGAAMAPTCA12
SCHEMBL8755112 0.88 CA12 (0.61) POLBKDM4EGAAMAPTCA12
SCHEMBL11862179 0.88 RARB (0.53) MAPTMCL1ALDH1A1
Myristic Acid SCHEMBL11881561 0.88 LTB4R (0.52) PTPN1ALDH1A1
SCHEMBL8654136 0.87 HSP90AA1 (0.50) POLBMAPTCA2PTPN1PTPN11
SCHEMBL487507 0.86 HSP90AA1 (0.62) POLBKDM4EGAAMAPTCA12
SCHEMBL27671146 0.86 KAT8 (0.55) MAPTMCL1ALDH1A1
SCHEMBL9616832 0.85 PKM (0.68) POLBKDM4EMAPTPTPN1PTPN11
SCHEMBL27750587 0.85 KDM4E (0.53) POLBKDM4EGAAMAPTCA12
SCHEMBL566628 0.85 RXRA (0.47) KDM4EGAAMAPTPTPN1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0598756-B1 ESTER COMPOSITION SHELL INT RESEARCH (NL) 1996-06-05 EP claimed
EP-0598756-A1 ESTER COMPOSITION. SHELL INT RESEARCH (NL) 1994-06-01 EP claimed
WO-1993002038-A1 ESTER COMPOSITION SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1993-02-04 WO claimed
EP-4245830-B1 LUBRICANT BASE OIL KAO CORP (JP) 2025-09-10 EP disclosed
US-12098341-B2 Lubricant base oil KAO CORPORATION (JP) 2024-09-24 US disclosed
WO-2024005270-A1 HYDROGEN GENERATOR 울산과학기술원 2024-01-04 WO disclosed
US-20230383208-A1 LUBRICANT BASE OIL KAO CORPORATION (JP) 2023-11-30 US disclosed
EP-4245830-A1 LUBRICANT BASE OIL Kao Corporation (JP) 2023-09-20 EP disclosed
WO-2022102651-A1 LUBRICANT BASE OIL 花王株式会社 2022-05-19 WO disclosed
CN-113848271-A Method for detecting related substances in levocetirizine hydrochloride oral solution 浙江核力欣健药业有限公司 2021-12-28 CN disclosed
CN-104198621-B A kind of Simultaneously test method of multiclass antiseptic Special migration in paper and paperboard Cigarette industry Co., Ltd in Yunnan (CN) 2016-04-13 CN disclosed
US-4454143-A Tricyclic antihistamines SCHERING CORPORATION (US) 1984-06-12 US disclosed
US-4395392-A Method for treating kidney stones ADRIA LABORATORIES INC. (US) 1983-07-26 US disclosed
US-4355036-A Tricyclic-substituted piperidine antihistamines SCHERING CORPORATION (US) 1982-10-19 US disclosed
US-4343812-A Antidepressant 2-amino-and-2-(substituted amino)-cis-hexahydro-carbazoles, compositions and use E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-08-10 US disclosed
US-4327087-A PARENTERAL PACKAGE OF AN ANTIBIOTIC SOLUTION SCHERING CORPORATION (US) 1982-04-27 US disclosed
US-4282233-A NO SEDATIVE EFFECT SCHERING CORPORATION (US) 1981-08-04 US disclosed
US-4268524-A Method of treating abnormal lipoprotein ratios with acylcarnitine CAVAZZA CLAUDIO 1981-05-19 US disclosed
US-4254134-A Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles ENDO LABORATORIES, INC. (US) 1981-03-03 US disclosed
US-4223022-A SALT OF NETILMICIN, PH AND COLOR STABLE SCHERING CORPORATION (US) 1980-09-16 US disclosed